7 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of AgeBacterial Infections and Mycoses, Infections, bacterial infectious disease, gram-positive bacterial infections, pneumococcal infection, streptococcal infectionRecruitingPhase 32026-10-05NCT07348692
CAYA Cancer Prospective Cohort StudyHemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, acute lymphoblastic leukemia, cancer, childhood malignant neoplasm, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmRecruitingNot stated2026-09-29NCT07632014
A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of AgeDNA Virus Infections, Herpesviridae infectious disease, Infections, Varicella Zoster Virus Infection, chickenpox, viral infectious diseaseRecruitingPhase 32026-05-29NCT06806137
A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric PopulationFlaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, vector-borne disease, viral hemorrhagic fever, viral infectious disease, yellow feverRecruitingPhase 32026-05-06NCT07103148
Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgePneumococcal ImmunizationActive, not recruitingPhase 32026-04-22NCT06736041
Study of the Safety of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of AgePneumococcal ImmunizationActive, not recruitingPhase 32026-04-13NCT06824194
Safety and Immunogenicity of an Investigational Pentavalent Meningococcal ABCYW Vaccine Against Meningococcal Disease in Children, Toddlers, and InfantsHealthy Volunteers; Meningococcal ImmunizationActive, not recruitingPhase 1 / Phase 22026-01-20NCT06647407